Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K L Phua

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Journal of Immunology Research|January 29, 2016
Towards Targeted Delivery Systems: Ligand Conjugation Strategies for mRNA Nanoparticle Tumor VaccinesKyle K L Phua
Health Services Research|August 1, 1994
Using Medicaid claims data to evaluate a large physician fee increaseM H Fox, K L Phua
Public Health Reports (Washington, D.C. : 1974)|May 1, 1995
Do increases in payments for obstetrical deliveries affect prenatal care?M H Fox, K L Phua
Biomolecules|August 1, 2017
Suppression of mRNA Nanoparticle Transfection in Human Fibroblasts by Selected Interferon Inhibiting Small Molecule CompoundsYang Liu, Manoj N Krishnan, Kyle K L Phua
Biomaterials|April 21, 2017
Non-linear enhancement of mRNA delivery efficiencies by influenza A derived NS1 protein engendering host gene inhibition propertyKyle K L Phua, Yi Liu, Shun Hui Sim
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 12, 2013
Transfection efficiency and transgene expression kinetics of mRNA delivered in naked and nanoparticle formatKyle K L Phua, Kam W Leong, Smita K Nair
ACS Nano|March 4, 2015
Aptamer nanomedicine for cancer therapeutics: barriers and potential for translationYeh-Hsing Lao, Kyle K L Phua, Kam W Leong
Nanoscale|June 7, 2014
Messenger RNA (mRNA) nanoparticle tumour vaccinationKyle K L Phua, Smita K Nair, Kam W Leong
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 27, 2021
Sustained release of PKR inhibitor C16 from mesoporous silica nanoparticles significantly enhances mRNA translation and anti-tumor vaccinationWei Zhang, Yi Liu, Jas Min Chin, et al.
Scientific Reports|August 21, 2019
Messenger RNA translation enhancement by immune evasion proteins: a comparative study between EKB (vaccinia virus) and NS1 (influenza A virus)Yi Liu, Jas Min Chin, En Lin Choo, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of Immunology Research|January 29, 2016
Towards Targeted Delivery Systems: Ligand Conjugation Strategies for mRNA Nanoparticle Tumor VaccinesKyle K L Phua
Health Services Research|August 1, 1994
Using Medicaid claims data to evaluate a large physician fee increaseM H Fox, K L Phua
Public Health Reports (Washington, D.C. : 1974)|May 1, 1995
Do increases in payments for obstetrical deliveries affect prenatal care?M H Fox, K L Phua
Biomolecules|August 1, 2017
Suppression of mRNA Nanoparticle Transfection in Human Fibroblasts by Selected Interferon Inhibiting Small Molecule CompoundsYang Liu, Manoj N Krishnan, Kyle K L Phua
Biomaterials|April 21, 2017
Non-linear enhancement of mRNA delivery efficiencies by influenza A derived NS1 protein engendering host gene inhibition propertyKyle K L Phua, Yi Liu, Shun Hui Sim
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 12, 2013
Transfection efficiency and transgene expression kinetics of mRNA delivered in naked and nanoparticle formatKyle K L Phua, Kam W Leong, Smita K Nair
ACS Nano|March 4, 2015
Aptamer nanomedicine for cancer therapeutics: barriers and potential for translationYeh-Hsing Lao, Kyle K L Phua, Kam W Leong
Nanoscale|June 7, 2014
Messenger RNA (mRNA) nanoparticle tumour vaccinationKyle K L Phua, Smita K Nair, Kam W Leong
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 27, 2021
Sustained release of PKR inhibitor C16 from mesoporous silica nanoparticles significantly enhances mRNA translation and anti-tumor vaccinationWei Zhang, Yi Liu, Jas Min Chin, et al.
Scientific Reports|August 21, 2019
Messenger RNA translation enhancement by immune evasion proteins: a comparative study between EKB (vaccinia virus) and NS1 (influenza A virus)Yi Liu, Jas Min Chin, En Lin Choo, et al.
Pageof 2